Relative Strength Chart BeOne Medicines AG

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 09/05/2026 am IST			5-day change	1st Jan Change
312.12 ^USD	-1.54%		+6.21%	+2.74%

29/04	BeOne Medicines Receives US FDA Priority Review for Tevimbra Combination Therapy	MT
29/04	BeOne Medicines Ltd. Receives Priority Review For Tevimbra In Combination With Ziihera And Chemotherapy For First-Line Her2-Positive Gastroesophageal Adenocarcinoma	CI

End-of-day quotes

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	BEONE MEDICINES AG	Other Biotechnology & Medical Research	-1.54%	+6.21%	+2.74%	+34.54%	+0.05%	3.47TCr